| Newswire Search | Up to 90 Days | 100 stories | 65 Publishers |
| Topic | # Mentions | Topic Reach |
|---|---|---|
| glp | 56 | - |
| eli lilly | 8 | - |
| health | 4 | - |
| costco | 3 | - |
| Byline | Articles Written | Avg Reach |
|---|---|---|
| n/a | 47 | - |
| Elaine Watson | 4 | - |
| Jasmine Pennic | 4 | - |
| Shane Smith | 3 | - |
| ArcaMax Publishing, Inc. | 2 | - |
| Kate Ashford, CSA® | 2 | - |
| President Donald Trump | 2 | - |
| Cara Lynn Shultz | 2 | - |
| Ally Marotti | 1 | - |
| Jessica Jani | 1 | - |
| Schuyler Mitchell | 1 | - |
| Tamilore Oshikanlu | 1 | - |
| Caresse Jackman | 1 | - |
| Carissa Mosness | 1 | - |
| Ed Cara | 1 | - |
| David Kelly | 1 | - |
| Cailey Griffin | 1 | - |
| Allison Nemetz | 1 | - |
| Kate Hogan | 1 | - |
| MENU - ORDER AI | 1 | - |
Execution: 19.33 Seconds. 128.71 mb used.
Obesity drugs may spur licensing, distribution deals for Indian drugmakers after patent expires
The WHO learned to love ‘anti-obesity’ jabs in 2025. I don’t fully agree, but I get it
New Year, new scam: Fraudsters target dieters with fake weight loss drugs
4 anti-aging approaches revealed in 2025 that may help Americans live longer
New Medicare BALANCE Program Could Slash GLP-1 Costs to $50 a Copay—Here’s Who Qualifies and When It Starts